Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Other Working Capital | -129,000 | -455,000 | 150,000 | 897,000 | -989,000 |
| Other Operating Activity | 3,214,000 | 2,941,000 | 2,230,000 | 2,217,000 | 2,707,000 |
| Operating Cash Flow | $3,085,000 | $2,486,000 | $2,380,000 | $3,114,000 | $1,718,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -382,000 | -364,000 | -524,000 | -314,000 | -269,000 |
| Net Acquisitions | -2,432,000 | -940,000 | -296,000 | -273,000 | -184,000 |
| Purchase Of Investment | 31,000 | -98,000 | -15,000 | -95,000 | -26,000 |
| Sale Of Investment | 84,000 | 9,000 | 97,000 | -68,000 | 81,000 |
| Purchase Sale Intangibles | -286,000 | -1,113,000 | -418,000 | -560,000 | -189,000 |
| Other Investing Activity | 113,000 | 168,000 | 82,000 | 89,000 | 91,000 |
| Investing Cash Flow | $-2,872,000 | $-2,413,000 | $-1,077,000 | $-1,221,000 | $-520,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,502,000 | 1,001,000 | 51,000 | 38,000 | -25,000 |
| Debt Issued | 0 | 4,976,000 | 0 | 0 | -10,000 |
| Debt Repayment | -2,636,000 | -7,000 | -287,000 | -1,247,000 | -1,404,000 |
| Common Stock Issued | 5,000 | 6,000 | 21,000 | 4,000 | 4,000 |
| Dividend Paid | -17,000 | -3,033,000 | -2,000 | -1,410,000 | -22,000 |
| Other Financing Activity | -76,000 | -915,000 | -74,000 | -111,000 | -62,000 |
| Financing Cash Flow | $-1,222,000 | $2,028,000 | $-291,000 | $-2,726,000 | $-1,519,000 |
| Exchange Rate Effect | -6,000 | -46,000 | 6,000 | -19,000 | -36,000 |
| Beginning Cash Position | 7,692,000 | 5,637,000 | 4,619,000 | 5,471,000 | 5,828,000 |
| End Cash Position | 6,677,000 | 7,692,000 | 5,637,000 | 4,619,000 | 5,471,000 |
| Net Cash Flow | $-1,009,000 | $2,101,000 | $1,012,000 | $-833,000 | $-321,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,085,000 | 2,486,000 | 2,380,000 | 3,114,000 | 1,718,000 |
| Capital Expenditure | -668,000 | -1,605,000 | -946,000 | -879,000 | -483,000 |
| Free Cash Flow | 2,417,000 | 881,000 | 1,434,000 | 2,235,000 | 1,235,000 |